Commerzbank Aktiengesellschaft’s Pacific Biosciences PACB Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-159,172	Closed	-$605K	–	965
2016 Q4	$605K	Sell	159,172 -34,653	-18%	-$252K	0.01%	557
2016 Q3	$1.74M	Sell	193,825 -14,428	-7%	-$121K	0.03%	358
2016 Q2	$1.47M	Buy	208,253 +159,100	+324%	+$1.45M	0.01%	419
2016 Q1	$418K	Sell	49,153 -31,131	-39%	-$306K	﹤0.01%	749
2015 Q4	$1.05M	Buy	+80,284	New	+$720K	0.01%	632

Other funds holding PACB

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Commerzbank Aktiengesellschaft's PACB Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of Pacific Biosciences (PACB) in Q1 2017, closing a stake of 159,172 shares — an estimated $605K sold.

Commerzbank Aktiengesellschaft first reported a position in PACB in Q4 2015 and held it in 5 quarters. The position peaked at $1.74M in Q3 2016. 106 funds tracked by Wall St. Rank hold PACB as of Q1 2017.

Commerzbank Aktiengesellschaft reported no remaining Pacific Biosciences position as of Q1 2017 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 159,172 Pacific Biosciences shares in Q1 2017, an estimated $605K.
Commerzbank Aktiengesellschaft first reported a position in Pacific Biosciences in Q4 2015 and held it in 5 quarters.
Commerzbank Aktiengesellschaft's Pacific Biosciences position peaked at $1.74M in Q3 2016.
106 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.